Abstract: The anti-canine N-terminal pro-atrial natriuretic peptide antibodies (anti-canine NT-proANP antibodies) according to the present invention comprise anti-canine NT-proANP recognizing a partial portion or a whole portion of the amino acid sequence 31 to 67 of canine NT-proANP and anti-canine NT-proANP recognizing a partial portion or a whole portion of the amino acid sequence 68 to 98 thereof. The anti-canine NT-proANP antibodies are useful for immunologically measuring canine NT-proANP involved in heart diseases and infections of companion animals such as dogs, such as heart failure, mitral valve insufficiency and filariasis. The immunochromatographic assay using the immunochromatographic means such as immunochromatographic strip is extremely convenient and simple for measuring canine NT-proANP and is used as hand-carried and simple devices.

Abstract: Methods for measuring an endocrine substance, such as feline insulin, in a biological sample taken from an animal with high accuracy, rapidity and brevity. The methods involve pre-treating a biological sample by removing an autoantibody bound to an endocrine substance present in a sample and measuring the endocrine substance after the pre-treatment. The methods can be used to measure autoantibody bound to an endocrine substance in the sample. Methods for diagnosis and treatment of diseases associated with endocrine substances are disclosed involving measuring an autoantibody value for an endocrine substance in a biological sample.

Abstract: The present invention provides a method for the measurement capable of measuring an endocrine substance such as feline insulin in an analyte of an animal such as feline or the like with high accuracy, rapidity and brevity. The method for the measurement of the endocrine substance in the analyte according to the present invention comprises pre-treating the analyte derived from the animal such as feline or the like by removing an autoantibody bound to the endocrine substance present in the analyte therefrom and measuring the endocrine substance in the pre-treated analyte. Further, the present invention can measure a value of the autoantibody bound to the endocrine substance in the analyte. In addition, the present invention allows a diagnosis and treatment of diseases associated with the endocrine substance by measuring the autoantibody value of the endocrine substance in the analyte.

Abstract: The present invention provides a method for the measurement of apoB-48, which involves measuring the apoB-48 by diluting a sample with a tris-buffer and, as needed, a surfactant and reacting the diluted sample with an anti-apoB-48 monoclonal antibody, and a kit for measuring the apoB-48 by using the above method. The method and the kit can accurately, rapidly and readily measure the apoB-48 particularly in blood. The method for the measurement of the apoB-48 and the kit to be used therefor are applicable to diagnosis of diseases associated with the apoB-48 and assessment of an efficacy of an ingredient of medicine for treating hyperlipidemia and an ingredient of functional food by measuring an increase or decrease of the apoB-48 in blood.